# PURSPEC Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/purspec-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Total disclosed funding: $14M
- Latest round: Series A (May 15, 2024)
- Investors on record: 4

## About

Based in Beijing, China and established in 2017, PURSPEC Technologies is a technology company which focuses on R&D and manufacture of mass spectrometer and provides service of mass spectrometry analysis. In May 2024, the firm raised a series A+ funding for CNY 100 million. As of 2024, the company has cooperated with Tsinghua University, Purdue University, Huashan Hospital Affiliated to Fudan University, Peking Union Medical College Hospital and other units.

The company's main products include portable mass spectrometry instruments, MS Mate mass spectrometer in-situ ionization ion source and OAnalyzer lipid double bond positioning analysis system. Its products are used in on-site testing, scientific research and other fields. The company’s revenue is generated by providing mass spectrometry detection equipment.

The company’s revenue is generated by providing mass spectrometry detection equipment.

The company will use the series A+ funding for product R&D registration and overseas sales.

## Funding rounds

- Series A, May 15, 2024, $14M — SinoKing Capital
- Series A, Aug 31, 2018 — TusStar, Guoqian Venture Capital, Qihang Capital
- Angel, Dec 28, 2017 — TusStar

## Investors

- TusStar (https://capitalatlas.ai/funds/tusstar) — Angel, Series A
- Guoqian Venture Capital (https://capitalatlas.ai/funds/guoqian-venture-capital) — Series A
- Qihang Capital (https://capitalatlas.ai/funds/qihang-capital) — Series A
- SinoKing Capital (https://capitalatlas.ai/funds/sinoking-capital) — Series A